IMPLANT SCIENCES CORP 4
4 · IMPLANT SCIENCES CORP · Filed Jul 3, 2014
Insider Transaction Report
Form 4
IMPLANT SCIENCES CORPOTCBB:IMSC
BOLDUC GLENN D
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-07-02+300,000→ 300,000 totalExercise: $1.10Exp: 2024-07-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-third of these options will vest upon the last to occur of (i)the addition of the Issuer's QS-B220 product to the Transportation Security Administration (TSA) Qualified Product List for passenger checkpoint screening, (ii)the execution of an indefinite delivery/indefinite quantity contract with the TSA, and (iii) receipt of orders under that contract totaling not less than $20 million. The remaining options will vest in two equal installments on the first and second anniversaries of the initial vesting date.